Fundraising Fox
/Companies
Sign in

Novocuff

Mountain View, US · Founded 2022 · Delaware corporation · 11 employees on LinkedIn · 5 known investors

Find your way into Novocuff

599 people in our graph can introduce you to the Novocuff team.

Sign up to see every warm intro you have to Novocuff

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Novocuff team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Novocuff is a medical device company developing the Novocuff Cervical Control System, an investigational device aimed at improving outcomes for pregnancies affected by preterm prelabor rupture of membranes (PPROM) or cervical shortening. It focuses on maternal and infant health related to preterm birth complications.

FemTechHealthtechMedical Devices

Founders & leadership

DLDonald Lee
Donald LeeCo-Founder & COO
ADAmelia Degenkolb
Amelia DegenkolbChief Executive OfficerAmelia Degenkolb has worked in product development and regulatory strategy for FDA-regulated medical device companies, with experience in clinical education and cross-functional stakeholder alignment. She is Executive Officer and Director at Novocuff, which develops the investigational Novocuff Cervical Control System to address preterm birth complications.
AD
Amy Degenkolb

Board

LD
Lilly DeSouza BurrBoard director
CL
Curt LaBelleBoard director
RSRebecca Shmukler
Rebecca ShmuklerBoard MemberPrincipal at Laerdal Million Lives Fund
SPShacey Petrovic
Shacey PetrovicChairpersonExecutive Officer, Director at Axena Health

Investors · 5

Foreground Capitallisted by Foreground CapitalBoston
Laerdal Million Lives Fundlisted by Laerdal Million Lives FundSan Francisco · $1M – $5M

How we know: a partner's Signal profile · Not right? Tell us

Global Health Investment FundreportedNew York

How we know: a partner's Signal profile · Not right? Tell us

Tullis Health InvestorsinferredPalm Beach Gardens · $500K – $10M

How we know: board seat on SEC Form D · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$6.8M disclosed across 1 round · 2024

▶$6.8MraisedJul 2024 · 31 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Shacey PetrovicDirector
  • Donald LeeExecutive Officer
  • Lilly DeSouza BurrDirector
  • Curt LaBelleDirector
  • Rebecca ShmuklerDirector
  • Amelia DegenkolbExecutive Officer, Director
Offering amount
$28M
Amount sold
$6.8M
First sale
Jun 2024
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Novocuff Raises $26M in Series A Fundingfinsmes.com · Jul 2024

Frequently asked questions

What does Novocuff do?
Novocuff is a medical device company developing the Novocuff Cervical Control System, an investigational device aimed at improving outcomes for pregnancies affected by preterm prelabor rupture of membranes (PPROM) or cervical shortening. It focuses on maternal and infant health related to preterm birth complications.
Who are Novocuff's investors?
Novocuff's investors include Avestria Ventures, Foreground Capital, Laerdal Million Lives Fund, Global Health Investment Fund, Tullis Health Investors.
How much funding has Novocuff raised?
Novocuff has disclosed $6.8M raised across 1 round.
Where is Novocuff headquartered?
Novocuff is headquartered in Mountain View, US.